Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07588932 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Primary completion pushed from Oct 31, 2027 to Dec 31, 2027
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this trial is to study if the concomitant administration of Telmisartan, Cilostazol IR (immediate release), and Metformin ER (extended release) can help stroke survivors make greater gains in movement and recovery during robot-assisted arm and hand rehabilitation.
Trial Details
NCT Number NCT07588932
Lead Sponsor Spaulding Rehabilitation Hospital
Collaborators: Neuro-Innovators, Inc.
Conditions
(from sponsor)		 Stroke
Related terms Stroke
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov